Zsa Zsa Weerts

Efficacy and safety of peppermint oil in IBS 161 7 References 1. Weerts Z, Keszthelyi D, Vork L, et al. A Novel Ileocolonic Release Peppermint Oil Capsule for Treatment of Irritable Bowel Syndrome: A Phase I Study in Healthy Volunteers. Adv Ther 2018;DOI 10.1007/ s12325-018-0802-1. 2. Mearin F, Lacy B, Chang L, et al. Bowel Disorders. Gastroenterology 2016;DOI 10.1053/j.gastro.2016.02.031. 3. Van den Houte K. Carbone F. Pannemans J, et al. Prevalence and impact of self-reported irritable bowel symptoms in the general population. United European Gastroenterol J 2018;7: 307-315. 4. Jossan N, Simren M, Sperber A, et al. Health Care Utilization for Rome IV Irritable Bowel Syndrome; A Three-Country Survey in the General Population. Gastroenterology 2017;152: S68. 5. Canavan C, West J, Card T. Review article: the economic impact of the irritable bowel syndrome. Aliment Pharmacol Ther 2014;40:1023-1034. 6. Corsetti M, Whorwell P. Novel pharmacological therapies for irritable bowel syndrome. Expert Rev Gastroenterol Hepatol.2016;10:807-815. 7. Hawthorn M, Ferrante J, Luchowski E, et al. The actions of peppermint oil and menthol on calcium channel dependent processes in intestinal, neuronal and cardiac preparations. Aliment Pharmacol Ther 1988;2:101-118. 8. Harrington A, Hughes P, Martin C, et al. A novel role for TRPM8 in visceral afferent function. Pain 2011;152:1459-1468. 9. Bautista D, Siemens J, Glazer J, et al. The menthol receptor TRPM8 is the principal detector of environmental cold. Nature 2007;448:204-208. 10. Karashima Y, Damann N, Prenen J, et al. Bimodal action of menthol on the transient receptor potential channel TRPA1. J CNeurosci 2007;27:9874-9884. 11. Walstab J, Wohlfarth C, Hovius R, et al. Natural compounds boldine and menthol are antagonists of human 5-HT3 receptors: implications for treating gastrointestinal disorders. Neurogastroenterol Motil 2014;26(6):810-820. 12. Trombetta D, Castelli F, Sarpietro M, et al. Mechanisms of antibacterial action of three monoterpenes. Antimicrob Agents Chemother 2005;49:2474-2478. 13. Botschuijver S, Welting O, Levin E, et al. Reversal of visceral hypersensitivity in rat by Menthacarin((R)) , a proprietary combination of essential oils from peppermint and caraway, coincides with mycobiome modulation. Neurogastroenterol Motil 2018;DOI 10.1111/nmo.13299. 14. Rajkowska K, Otlewska A, Kunicka-Styczynska A, et al. Candida albicans Impairments Induced by Peppermint and Clove Oils at Sub- Inhibitory Concentrations. Int J Mol Sci 2017;18. 15. Galeotti N, Di Cesare Mannelli L, Mazzanti G, et al. Menthol: a natural analgesic compound. Neurosci Lett 2002; 322:145-148. 16. White D, Thompson S, Wilson C, et al. A pharmacokinetic comparison of two delayed- release peppermint oil preparations, Colpermin and Mintec, for treatment of the irritable bowel syndrome. Int J Pharm 1987;40:151-155. 17. Cash B, Epstein M, Shah S. A Novel Delivery System of Peppermint Oil Is an Effective Therapy for Irritable Bowel Syndrome Symptoms. Dig Dis Sci 2016; 61:560-571. 18. Ford A, Moayyedi P, Chey W, et al. American College of Gastroenterology Monograph on Management of Irritable Bowel Syndrome. Am J Gastroenterol 2018;DOI 10.1038/s41395- 018-0084-x. 19. Mosaffa-Jahromi M, Lankarani K, Pasalar M, et al. Efficacy and safety of enteric coated capsules of anise oil to treat irritable bowel syndrome. J Ethnopharmacol 2016;194:937- 946. 20. Merat S, Khalili S, Mostajabi P, et al. The effect of enteric-coated, delayed-release peppermint oil on irritable bowel syndrome. Dig Dis Sci 2010, 55 , 1385-1390. 21. Cappello G, Spezzaferro M, Grossi L, et al. Peppermint oil (Mintoil) in the treatment of irritable bowel syndrome: a prospective double blind placebo-controlled randomized trial. Dig Liver Dis 2007;39:530-536. 22. Liu J, Chen G, Yeh H, et al. Enteric-coated peppermint-oil capsules in the treatment of